These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 7847331)

  • 1. Profound thrombocytopenia complicating dietary erucic acid therapy for adrenoleukodystrophy.
    Crowther MA; Barr RD; Kelton J; Whelan D; Greenwald M
    Am J Hematol; 1995 Feb; 48(2):132-3. PubMed ID: 7847331
    [No Abstract]   [Full Text] [Related]  

  • 2. Lorenzo's oil and lymphocytopenia.
    Unkrig CJ; Schröder R; Scharf RE
    N Engl J Med; 1994 Feb; 330(8):577. PubMed ID: 8204158
    [No Abstract]   [Full Text] [Related]  

  • 3. Thrombocytopenia associated with use of Lorenzo's oil.
    Chai BC; Siminoski K
    Am J Hematol; 1993 Dec; 44(4):290-1. PubMed ID: 8238006
    [No Abstract]   [Full Text] [Related]  

  • 4. Proceedings of the 4th International Workshop of the Adrenoleukodystrophy International Research Group (ALD-IRG), University of York, 3 September 1998.
    Alger S; Green A; Köhler W; Sokolowski P; Moser H
    J Inherit Metab Dis; 2000 Jul; 23(5):449-52. PubMed ID: 10947198
    [No Abstract]   [Full Text] [Related]  

  • 5. Severely depressed natural killer cell activity of patients with adrenoleukodystrophy under treatment with Lorenzo's oil.
    Sedlmayr P; Plecko B; Paschke E; Zenz W; Ramschak H; Toplak H; Wascher TC; Wilders-Truschnig M; Stöckler S
    J Inherit Metab Dis; 1995; 18(1):101-2. PubMed ID: 7623436
    [No Abstract]   [Full Text] [Related]  

  • 6. Lorenzo's oil therapy of adrenoleukodystrophy.
    DiGregorio VY; Schroeder DJ
    Ann Pharmacother; 1995 Mar; 29(3):312-3. PubMed ID: 7606079
    [No Abstract]   [Full Text] [Related]  

  • 7. Treatment of X-linked adrenoleukodystrophy with Lorenzo's oil.
    Moser HW
    J Neurol Neurosurg Psychiatry; 1999 Sep; 67(3):279-80. PubMed ID: 10449544
    [No Abstract]   [Full Text] [Related]  

  • 8. Lorenzo's oil and thrombocytopenia in patients with adrenoleukodystrophy.
    Zinkham WH; Kickler T; Borel J; Moser HW
    N Engl J Med; 1993 Apr; 328(15):1126-7. PubMed ID: 8455677
    [No Abstract]   [Full Text] [Related]  

  • 9. Thrombocytopenia induced by erucic acid therapy in patients with X-linked adrenoleukodystrophy.
    Zierz S; Schröder R; Unkrig CJ
    Clin Investig; 1993 Oct; 71(10):802-5. PubMed ID: 8305837
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lorenzo's oil: advances in the treatment of neurometabolic disorders.
    Ferri R; Chance PF
    Arch Neurol; 2005 Jul; 62(7):1045-6. PubMed ID: 16009756
    [No Abstract]   [Full Text] [Related]  

  • 11. Adrenoleukodystrophy and the mitochondrial connection: clues for supplementing Lorenzo's oil.
    Moraes CT
    Brain; 2013 Aug; 136(Pt 8):2339-41. PubMed ID: 23842565
    [No Abstract]   [Full Text] [Related]  

  • 12. Complicated lessons: Lorenzo Odone and medical miracles.
    Lerner BH
    Lancet; 2009 Mar; 373(9667):888-9. PubMed ID: 19291841
    [No Abstract]   [Full Text] [Related]  

  • 13. Effect of erucic acid on platelets in patients with adrenoleukodystrophy.
    Kickler TS; Zinkham WH; Moser A; Shankroff J; Borel J; Moser H
    Biochem Mol Med; 1996 Apr; 57(2):125-33. PubMed ID: 8733890
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lipoid pneumonia as a complication of Lorenzo's oil therapy in a patient with adrenoleukodystrophy.
    Majori M; Scarascia A; Anghinolfi M; Pisi R; Gnetti L; Casalini AG
    J Bronchology Interv Pulmonol; 2014 Jul; 21(3):271-3. PubMed ID: 24992138
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Platelets in treated adrenoleukodystrophy: a brief report.
    Revell P; Green A; Green S
    J Inherit Metab Dis; 1995; 18(5):635-7. PubMed ID: 8598646
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Positive effects with Lorenzo's oil.
    Siva N
    Lancet Neurol; 2005 Sep; 4(9):529. PubMed ID: 16136703
    [No Abstract]   [Full Text] [Related]  

  • 17. A two-year trial of oleic and erucic acids ("Lorenzo's oil") as treatment for adrenomyeloneuropathy.
    Aubourg P; Adamsbaum C; Lavallard-Rousseau MC; Rocchiccioli F; Cartier N; Jambaqué I; Jakobezak C; Lemaitre A; Boureau F; Wolf C
    N Engl J Med; 1993 Sep; 329(11):745-52. PubMed ID: 8350883
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Very long chain fatty acids in X-linked adrenoleukodystrophy brain after treatment with Lorenzo's oil.
    Poulos A; Gibson R; Sharp P; Beckman K; Grattan-Smith P
    Ann Neurol; 1994 Nov; 36(5):741-6. PubMed ID: 7979219
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improvement of clinical and MRI findings in a boy with adrenoleukodystrophy by dietary erucic acid therapy.
    Maeda K; Suzuki Y; Yajima S; Asano J; Yamaguchi S; Matsumoto N; Borel J; Moser HW; Orii T
    Brain Dev; 1992 Nov; 14(6):409-12. PubMed ID: 1492654
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Making rare diseases a public-health and research priority.
    Lancet; 2008 Jun; 371(9629):1972. PubMed ID: 18555895
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.